Shutting Down a Protein Could Reduce Glucose Production in Liver, Blood Sugar Levels

We think this strategy could lead to more effective drugs for Type-2 diabetes, said Brian Finck, associate professor of medicine at Washington University School of Medicine.

Offering a promising strategy to treat people with Type-2 diabetes, researchers have found that shutting down a liver protein could reduce glucose production in the liver and lower blood sugar levels.

"We think this strategy could lead to more effective drugs for Type-2 diabetes," said principal investigator Brian Finck, associate professor of medicine at Washington University School of Medicine in St. Louis.

Metabolic Surgery May Offer Better Control Over Diabetes In Obese Individuals
Fewer diabetes-related complications and a reduction in the risk factors of cardiovascular disease were observed in surgical patients in this study.

Conventional treatments for Type 2 diabetes focus on making the body more sensitive to insulin, the hormone that lowers blood sugar.

"A drug that shuts down glucose production has the potential to help millions of people affected by the most common form of diabetes," Finck noted.

For the study, the researchers worked with the US-based biopharmaceutical company Metabolic Solutions Development Co.

Children Born in Famine-Hit Regions Are More Prone to Develop Type-II Diabetes as Adults
There was a 1.3 fold rise in the odds of Type 2 diabetes in famine regions and there was no diabetes increase among individuals born in regions with no famine.

The company is involved in clinical trials that are evaluating the drug compound MSDC-0602 as a treatment for diabetes.

The new study demonstrated that the compound works, at least in part, by inhibiting a protein that is key to glucose production in the liver.

Dietary Changes, Lifestyle Modifications Help Fight Diabetes, Alzheimer's
Avoiding saturated fat, increasing consumption of monounsaturated and omega-3 fatty acids and instituting a program of regular exercise promote a healthy blood sugar.

In experiments with mice, the research team cut sugar production in liver cells by inhibiting a key protein involved in transporting pyruvate, a building block of glucose, from the bloodstream into the energy factories of liver cells, called mitochondria.

In addition to diabetes, the researchers also think that interfering with pyruvate transport may help patients with nonalcoholic fatty liver disease, a condition common in people with obesity.

Diabetic Retinopathy Screening For Children With Type 2 Diabetes Before Age 15 Is Unnecessary
Children with diabetes consistently show no signs for diabetic retinopathy. But, it is very important to have annual eye exams once the risk of vision loss develops.

The research was published online in the journal Cell Metabolism.

Source-IANS